HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phacomatosis pigmentokeratotica: a patient with the rare melanocytic-epidermal twin nevus syndrome.

Abstract
We describe a 10-year-old girl affected with a speckled lentiginous nevus and an epidermal nevus of the organoid type on corresponding parts of the body. On histopathological examination, the lesions showed epidermal hyperpigmentation and melanocytic hyperplasia on the one hand and verrucous epidermal acanthosis with sebaceous hyperplasia on the other hand. Except for a minor deviation of the spine, the patient had no obvious extracutaneous symptoms. Happle et al. have recently interpreted the rare co-occurrence of these two types of nevi in spatial proximity as an example of twin spotting in human skin and proposed the name 'phacomatosis pigmentokeratotica'. In most cases, additional skeletal or neurological anomalies are found. These are dissimilar from the extracutaneous symptoms of the sebaceous nevus syndrome, from which phacomatosis pigmentokeratotica should be distinguished. Molecular studies are needed to prove the concept of twin spotting and to reveal a link to the extracutaneous manifestations.
AuthorsB Hermes, B Cremer, R Happle, B M Henz
JournalDermatology (Basel, Switzerland) (Dermatology) Vol. 194 Issue 1 Pg. 77-9 ( 1997) ISSN: 1018-8665 [Print] Switzerland
PMID9031800 (Publication Type: Case Reports, Journal Article)
Topics
  • Child
  • Diagnosis, Differential
  • Epidermis (pathology)
  • Female
  • Follow-Up Studies
  • Hamartoma (pathology)
  • Humans
  • Hyperpigmentation (pathology)
  • Hyperplasia
  • Melanocytes (pathology)
  • Molecular Biology
  • Nevus (pathology)
  • Nevus, Pigmented (pathology)
  • Sebaceous Glands (pathology)
  • Skin Diseases (pathology)
  • Skin Neoplasms (pathology)
  • Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: